Sphera Funds Management Ltd. Werewolf Therapeutics, Inc. Transaction History
Sphera Funds Management Ltd.
- $363 Million
- Q2 2025
A detailed history of Sphera Funds Management Ltd. transactions in Werewolf Therapeutics, Inc. stock. As of the latest transaction made, Sphera Funds Management Ltd. holds 626,810 shares of HOWL stock, worth $752,172. This represents 0.19% of its overall portfolio holdings.
Number of Shares
626,810
Previous 626,810
-0.0%
Holding current value
$752,172
Previous $608,000
12.34%
% of portfolio
0.19%
Previous 0.16%
Shares
6 transactions
Others Institutions Holding HOWL
# of Institutions
66Shares Held
23.6MCall Options Held
0Put Options Held
0-
Ra Capital Management, L.P. Boston, MA6.68MShares$8.02 Million0.16% of portfolio
-
Mpm Asset Management LLC Cambridge, MA4.31MShares$5.17 Million10.84% of portfolio
-
Bio Impact Capital LLC Cambridge, MA2.41MShares$2.89 Million0.51% of portfolio
-
Bank Of America Corp Charlotte, NC2.13MShares$2.55 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.59MShares$1.91 Million0.0% of portfolio
About Werewolf Therapeutics, Inc.
- Ticker HOWL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,529,400
- Market Cap $35.4M
- Description
- Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapeutics engineered to stimulate the body's immune system for the treatment of cancer. The company, through its proprietary PREDATOR platform, designs conditionally activated molecules that stimulate adaptive and innate immunity for addressing the limitations of conventional ...